The goal of this study was to compare the effectiveness of three treat
ments aiming to reduce nasal airflow resistance (NR): an external nasa
l strip device (Respir+), an internal nasal mechanical dilator (Nozove
nt), and a topical decongestant (Pernazene). NR was estimated by activ
e posterior rhinometry at both a 0.5 L/s flow (NRF) and a 1 cm H2O pre
ssure (NRp), under four conditions: in the basal state, with Respir+,
with Nozovent, and after treatment with Pernazene. The efficacy of eac
h treatment was assessed by the percentage changes in NRF and NRP (%NR
F and %NRP, respectively). The study was performed in 15 healthy subje
cts, The efficacy of the treatments was significantly different, depen
ding on whether it was evaluated by NRF or by NRP (p<0.02), with %NRF
and %NRP values, respectively, equal to the following: 88+/-20% and 91
+/-14% with Respir+, 58+/-17% and 70+/-13% with Nozovent, and 55+/-29%
and 69+/-22% with Pernazene. NRF remained unchanged with Respir+, whe
reas it significantly decreased with Nozovent and Pernazene (p<0.0001)
. No significant difference was observed between the effects of the tw
o latter treatments. These results demonstrate that Nozovent, which in
volves no risk of side effects or drug interactions, is an effective t
reatment to improve nasal breathing. Nozovent might therefore be recom
mended as an alternative to topical decongestants, for certain subject
s presenting with nasal obstruction.